GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OHEL:NANOFH) » Definitions » Operating Margin %

Nanoform Finland (OHEL:NANOFH) Operating Margin % : -678.55% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Nanoform Finland's Operating Income for the three months ended in Sep. 2024 was €-5.25 Mil. Nanoform Finland's Revenue for the three months ended in Sep. 2024 was €0.77 Mil. Therefore, Nanoform Finland's Operating Margin % for the quarter that ended in Sep. 2024 was -678.55%.

Good Sign:

Nanoform Finland PLC operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Nanoform Finland's Operating Margin % or its related term are showing as below:

OHEL:NANOFH' s Operating Margin % Range Over the Past 10 Years
Min: -14987.76   Med: -875.92   Max: -613.97
Current: -995.34


OHEL:NANOFH's Operating Margin % is ranked worse than
72.7% of 1011 companies
in the Biotechnology industry
Industry Median: -162.31 vs OHEL:NANOFH: -995.34

Nanoform Finland's 5-Year Average Operating Margin % Growth Rate was 25.80% per year.

Nanoform Finland's Operating Income for the three months ended in Sep. 2024 was €-5.25 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was €-24.16 Mil.


Nanoform Finland Operating Margin % Historical Data

The historical data trend for Nanoform Finland's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland Operating Margin % Chart

Nanoform Finland Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial -14,987.76 -2,827.22 -1,007.93 -613.97 -875.92

Nanoform Finland Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -796.10 -1,531.00 -1,083.89 -960.98 -678.55

Competitive Comparison of Nanoform Finland's Operating Margin %

For the Biotechnology subindustry, Nanoform Finland's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanoform Finland's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's Operating Margin % falls into.



Nanoform Finland Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Nanoform Finland's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-22.476 / 2.566
=-875.92 %

Nanoform Finland's Operating Margin % for the quarter that ended in Sep. 2024 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=-5.252 / 0.774
=-678.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanoform Finland  (OHEL:NANOFH) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Nanoform Finland Operating Margin % Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanoform Finland Business Description

Traded in Other Exchanges
Address
Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceuticals pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland Headlines

No Headlines